Ameritas Investment Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.9K | Hold |
5,253
| – | – | ﹤0.01% | 2207 |
|
|
2025
Q1 | $41.8K | Hold |
5,253
| – | – | ﹤0.01% | 2212 |
|
|
2024
Q4 | $28.5K | Hold |
5,253
| – | – | ﹤0.01% | 2482 |
|
|
2024
Q3 | $37.9K | Hold |
5,253
| – | – | ﹤0.01% | 2348 |
|
|
2024
Q2 | $57K | Hold |
5,253
| – | – | ﹤0.01% | 2073 |
|
|
2024
Q1 | $98.4K | Hold |
5,253
| – | – | ﹤0.01% | 1753 |
|
|
2023
Q4 | $114K | Hold |
5,253
| – | – | ﹤0.01% | 1646 |
|
|
2023
Q3 | $108K | Buy |
5,253
+887
| +20% | +$18.3K | ﹤0.01% | 1600 |
|
|
2023
Q2 | $205K | Buy |
4,366
+198
| +5% | +$9.31K | 0.01% | 1118 |
|
|
2023
Q1 | $175K | Hold |
4,168
| – | – | 0.01% | 1181 |
|
|
2022
Q4 | $178K | Buy |
4,168
+261
| +7% | +$11.1K | 0.01% | 1218 |
|
|
2022
Q3 | $152K | Hold |
3,907
| – | – | 0.01% | 1215 |
|
|
2022
Q2 | $126K | Buy |
+3,907
| New | +$126K | 0.01% | 1354 |
|
|
2018
Q2 | – | Sell |
-3,534
| Closed | -$569K | – | 3056 |
|
|
2018
Q1 | $569K | Buy |
3,534
+280
| +9% | +$45.1K | 0.03% | 710 |
|
|
2017
Q4 | $536K | Buy |
3,254
+220
| +7% | +$36.2K | 0.02% | 729 |
|
|
2017
Q3 | $249K | Hold |
3,034
| – | – | 0.01% | 946 |
|
|
2017
Q2 | $242K | Buy |
3,034
+497
| +20% | +$39.6K | 0.01% | 960 |
|
|
2017
Q1 | $180K | Buy |
+2,537
| New | +$180K | 0.01% | 1115 |
|